Fulgent Genetics (FLGT) Key Ratios

$19.53

up-down-arrow $-0.13 (-0.64%)

As on 04-Sep-2026 13:35EDT

Market cap

info icon

$540 Mln

Revenue (TTM)

info icon

$324 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 20.03 4.38 6.83 1.76 -18.66
EBIT -14.14 -37.81 -52.52 -9.71 -167.27
Net Profit -20.36 -57.26 -66.57 -31.16 -169.19
EPS -31.16 -71.50 -70.48 -37.89 -169.68
Book Value -- -- -2.27 -4.06 11.38
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -33.32-11.91-28.05-21.68-18.27
Net Margin info --10.46-26.05----
Return on equity info -7.710.16-7.88-5.39-3.76
Return on Capital info -7.580.12---5.35-3.72
Return on Assets info -7.090.01-6.94-4.97-3.48
Debt to Equity (x) info ----0.000.010.01
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
--
-5.35
-3.72
-13.66
11.54
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-7.88

Lower than Peers by 15.84

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-7.88
-5.39
-3.76
-13.97
11.82
Peer Median
7.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-6.94

Lower than Peers by 9.08

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-6.94
-4.97
-3.48
-12.80
10.76
Peer Median
2.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-28.05

Lower than Peers by 35.10

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-28.05
-21.68
-18.27
-60.02
29.89
Peer Median
7.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-26.05

Lower than Peers by 29.20

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-26.05
-18.75
-15.07
-58.03
23.17
Peer Median
3.16
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

6.83

Lower than Peers by 3.00

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
6.83
0.14
-0.02
-0.53
-0.38
Peer Median
9.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-52.52

Lower than Peers by 68.73

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-52.52
-35.08
70.17
-193.82
77.34
Peer Median
16.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-66.57

Lower than Peers by 83.75

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-66.57
-41.69
74.55
-217.03
37.44
Peer Median
17.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-70.48

Lower than Peers by 86.57

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-70.48
-0.41
0.75
-2.22
0.38
Peer Median
16.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-1.24

Lower than Peers by 6.36

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-1.24
--
--
--
--
Peer Median
5.12
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

0.00

Lower than Peers by 0.38

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
0.00
0.01
0.01
0.01
0.03
Peer Median
0.38
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.00

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
0.00
0.00
0.00
0.00
0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

6.34

Higher than Peers by 4.86

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
6.34
6.48
4.85
6.96
7.13
Peer Median
1.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

6.18

Higher than Peers by 4.79

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
6.18
6.35
4.74
6.88
7.08
Peer Median
1.38
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-381.71

Lower than Peers by 386.03

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
-381.71
-932.67
-304.62
-355.73
182.66
Peer Median
4.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

21.77

Higher than Peers by 8.65

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
21.77
28.39
27.17
19.86
12.13
Peer Median
13.12
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.27

Lower than Peers by 0.51

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
0.27
0.27
0.23
0.22
0.46
Peer Median
0.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
--
95.45
86.64
83.70
64.44
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
--
18.08
14.72
9.99
11.94
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
--
35.25
34.94
38.01
31.58
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
--
78.28
66.42
55.68
44.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
--
-13.36
-13.26
-5.13
6.43
Peer Median
33.81
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.55

Lower than Peers by 3.00

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
0.55
0.73
0.50
0.76
0.73
Peer Median
3.54
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

2.34

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
2.34
-10.48
-11.78
-3.06
2.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

540

Higher than Peers by 169

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Fulgent Genetics (FLGT)
540
--
--
--
--
Peer Median
371
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...